U.S. Stents Market Size & Outlook, 2023-2030
U.S. stents market, 2018-2030 (US$M)
Related Markets
U.S. stents market highlights
- The U.S. stents market generated a revenue of USD 5,048.3 million in 2023 and is expected to reach USD 6,413.7 million by 2030.
- The U.S. market is expected to grow at a CAGR of 3.5% from 2024 to 2030.
- In terms of segment, vascular was the largest revenue generating product in 2023.
- Non-vascular Stents is the most lucrative product segment registering the fastest growth during the forecast period.
Stents market data book summary
| Market revenue in 2023 | USD 5,048.3 million |
| Market revenue in 2030 | USD 6,413.7 million |
| Growth rate | 3.5% (CAGR from 2023 to 2030) |
| Largest segment | Vascular |
| Fastest growing segment | Non-vascular Stents |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Vascular, Non-vascular Stents |
| Key market players worldwide | Abbott Laboratories, B. Braun, BIOTRONIK, Biosensors, Boston Scientific Corp, Elixirr International PLC Ordinary Shares, Medtronic PLC, MicroPort Scientific Corp, Stryker Corp, Terumo Corp, W.L. Gore & Associates, BD, Conmed Corp, Meril Life |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.9% of the global stents market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. stents market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 1,524.6 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Stents Market Scope
Stents Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. stents market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to stents market will help companies and investors design strategic landscapes.
Vascular was the largest segment with a revenue share of 88.4% in 2023. Horizon Databook has segmented the U.S. stents market based on vascular, non-vascular stents covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. Stents Product Outlook (Revenue, USD Million, 2018-2030)
- Vascular
- Coronary Stents
- Peripheral Stents
- Iliac Artery Stents
- Femoral Artery Stents
- Carotid Artery Stents
- Renal Artery Stents
- Other Peripheral Stents
- Neurovascular Stents
- Intracranial Stents
- Flow Diverters
- Non-vascular Stents
- Gastrointestinal Stents
- Biliary
- Duodenal
- Colonic
- Pancreatic
- Esophageal Stents
- Pulmonary (Airway) Stents
- Silicone Airway
- Metallic Airway
- Urological Stents
- Others
- Gastrointestinal Stents
- Vascular
- U.S. Stents Material Outlook (Revenue, USD Million, 2018-2030)
- Metallic Stents
- Non-metallic Stents
- U.S. Stents End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Ambulatory Care Centers (ACS)
- Specialty Clinics
Reasons to subscribe to U.S. stents market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. stents market databook
-
Our clientele includes a mix of stents market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. stents market , including forecasts for subscribers. This country databook contains high-level insights into U.S. stents market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. stents market size, by product, 2018-2030 (US$M)
U.S. Stents Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
